Over 20,000 Americans are diagnosed each year with bone marrow failure syndromes. Environmental, chemical, and genetic factors have been linked to the development of lymphomas, leukemias, and myelodysplastic syndromes (MDS). Additionally, some anti-cancer drugs have been shown to themselves induce DNA damage and secondary cancers. In light of increasing societal exposure to toxic environmental agents that may be carcinogenic, including chemicals and pharmaceuticals, we face the potential for a rise in the incidence of bone marrow failure and malignancy. In order to better understand leukemia it may be necessary to examine it from the perspective that it is an environmental disease.

http://www.nyas.org/Events/Detail.aspx?cid=b4c60844-7a53-45d6-8640-9419c6353529

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.

http://www.ddtwc.com/index.php

The British Gynaecological Cancer Society Annual Scientific Meeting 2013 promises to serve as the central meeting point to discuss the latest advances and treatments in gynaecological oncology. Being held in conjunction with the Irish Gynaecological Cancer Society (IRGCS), BGCS 2013 is an influential platform for professionals from the specialties of obstetrics, gynaecology, oncology and radiology to network with colleagues from the UK and across Europe.

http://bgcsconference.com/

http://www2.kenes.com/mascc2013/pages/home.aspx

The European Society of Gynaecological Oncology’s annual
International Meeting is Europe’s landmark meeting on Gynaecological Oncology and offers professionals an excellent opportunity to discover the latest medical and scientific information on gynaecological cancer treatment and care.

http://www2.kenes.com/esgo18/Pages/Home.aspx

Building on the success of previous conferences, the theme of the 2013 meeting ‘Achieving Optimal Outcomes Through Multidisciplinary Care’ will reflect the need for collaboration and cooperation in producing the best possible outcomes in the treatment of lung cancer. It is also a reflection of the nature of the International Association for the Study of Lung Cancer which welcomes and encourages the participation of individuals from a wide range of professional backgrounds in its Conferences.

http://www.2013worldlungcancer.org/

The conference series on Bioactive Lipids in Cancer, Inflammation and Related Diseases was started in 1989 when its first conference was held in Detroit, Michigan. Subsequent meetings were held around the globe with the next conference scheduled for November 3 - 6, 2013 in San Juan, Puerto Rico.

The previous biennial conferences have been immensely successful in highlighting data from research at the cutting edge of science on the role of lipid mediators in various physiological and pathological processes. The goal of this meeting series is to promote the exchange of ideas between scientists of diverse backgrounds from around the world.  And to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflammation and inflammation induced diseases such as cardiovascular, diabetes, psoriasis, and Alzheimer's.

http://bioactivelipids.org/